DK1807698T3 - Assay til bestemmelse af aktiviteten af clostridialt toksin ved kombination af FRET og fluorescenspolarisering - Google Patents

Assay til bestemmelse af aktiviteten af clostridialt toksin ved kombination af FRET og fluorescenspolarisering

Info

Publication number
DK1807698T3
DK1807698T3 DK05858107.5T DK05858107T DK1807698T3 DK 1807698 T3 DK1807698 T3 DK 1807698T3 DK 05858107 T DK05858107 T DK 05858107T DK 1807698 T3 DK1807698 T3 DK 1807698T3
Authority
DK
Denmark
Prior art keywords
clostridial toxin
activity
fluorescence polarization
fluorophore
fret
Prior art date
Application number
DK05858107.5T
Other languages
English (en)
Inventor
Dudley J Williams
Marcella A Gilmore
Lance E Steward
Marc Verhagen
Kei Roger Aoki
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36074524&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1807698(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of DK1807698T3 publication Critical patent/DK1807698T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Prostheses (AREA)
DK05858107.5T 2004-09-22 2005-09-09 Assay til bestemmelse af aktiviteten af clostridialt toksin ved kombination af FRET og fluorescenspolarisering DK1807698T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/948,097 US7399607B2 (en) 2004-09-22 2004-09-22 Fluorescence polarization assays for determining clostridial toxin activity
PCT/US2005/032328 WO2007001358A2 (en) 2004-09-22 2005-09-09 Fluorescence polarization assays for determining clostridial toxin activity

Publications (1)

Publication Number Publication Date
DK1807698T3 true DK1807698T3 (da) 2010-09-20

Family

ID=36074524

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05858107.5T DK1807698T3 (da) 2004-09-22 2005-09-09 Assay til bestemmelse af aktiviteten af clostridialt toksin ved kombination af FRET og fluorescenspolarisering

Country Status (11)

Country Link
US (7) US7399607B2 (da)
EP (2) EP2107112A1 (da)
JP (2) JP2008513038A (da)
KR (1) KR101442246B1 (da)
AT (1) ATE472101T1 (da)
AU (1) AU2005333632B2 (da)
CA (1) CA2581231A1 (da)
DE (1) DE602005021981D1 (da)
DK (1) DK1807698T3 (da)
ES (2) ES2345780T3 (da)
WO (1) WO2007001358A2 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7332567B2 (en) * 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
US8022172B2 (en) * 2001-08-28 2011-09-20 Allergan, Inc. Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity
US7208285B2 (en) * 2001-08-28 2007-04-24 Allergan, Inc. Fret protease assays for botulinum serotype A/E toxins
US7374896B2 (en) * 2001-08-28 2008-05-20 Allergan, Inc. GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
US20080064054A1 (en) * 2001-08-28 2008-03-13 Ester Fernandez-Salas Fluorescence resonance energy transfer (fret) assays for clostridial toxin activity
US7183066B2 (en) * 2002-09-27 2007-02-27 Allergan, Inc. Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
US7399607B2 (en) 2004-09-22 2008-07-15 Allergan, Inc. Fluorescence polarization assays for determining clostridial toxin activity
WO2008036060A2 (en) * 2005-04-05 2008-03-27 Allergan, Inc. Clostridial toxin activity assays
PT1869459E (pt) * 2005-04-05 2010-08-10 Allergan Inc Ensaios fret à base de corantes lipofílicos para a actividade da toxina de clostrídeo
DE602006013481D1 (de) * 2005-09-19 2010-05-20 Allergan Inc Mit clostriedientoxin aktivierbare clostridientoxine
CA2602972C (en) * 2005-10-12 2013-09-24 Allergan, Inc. Assays of molecular or subcellular interactivity using depolarization after resonance energy transfer (daret)
US8003314B2 (en) 2007-04-16 2011-08-23 Diagnostic Hybrids, Inc. Methods for direct fluorescent antibody virus detection in liquids
US8753831B2 (en) * 2007-06-05 2014-06-17 City Of Hope Methods for detection of botulinum neurotoxin
EP2170400B1 (en) * 2007-07-10 2012-07-25 Medy-Tox, INC. Pharmaceutical liquid composition of botulinum toxin with improved stability
KR101609894B1 (ko) 2008-03-14 2016-04-08 알러간, 인코포레이티드 면역-기반 보툴리눔 독소 세로타입 ａ 활성 검정
KR101604515B1 (ko) * 2008-03-14 2016-03-17 알러간, 인코포레이티드 면역-기반 보툴리눔 독소 세로타입 ａ 활성 검정
RU2543650C2 (ru) * 2009-03-13 2015-03-10 Аллерган, Инк. Иммунологические тесты на активность эндопептидаз с измененной нацеленностью
KR20200146046A (ko) 2009-03-13 2020-12-31 알러간, 인코포레이티드 면역 기반 보툴리눔 독소 혈청형 ａ 활성 검정에 유용한 세포
US8129139B2 (en) 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
EP2483666A1 (en) 2009-10-02 2012-08-08 Allergan, Inc. In vitro method of determining changes in a protein environment
WO2013102088A2 (en) 2011-12-31 2013-07-04 Allergan, Inc. Highly Sensitive Cell-Based Assay to Detect the Presence of Active Botulinum Neurotoxin Serotype-A
KR102607322B1 (ko) 2012-01-04 2023-11-29 바이오메디슨, 인코퍼레이티드 보툴리눔 분석 감도를 증진시키기 위한 방법 및 화합물
US8962340B2 (en) 2012-12-03 2015-02-24 Src, Inc. Real-time assay for the detection of botulinum toxin
EP3270162B2 (en) 2013-08-09 2023-08-16 BioMadison, Inc. Botulinum toxin assay with improved sensitivity
KR20170026624A (ko) 2014-07-07 2017-03-08 알러간, 인코포레이티드 조직 샘플에서 절단된 snap25를 검출하는 방법
FR3053689B1 (fr) * 2016-07-06 2021-01-08 Univ Claude Bernard Lyon Polypeptides substrats des proteases de la famille des astacines et leurs utilisations
AU2017327369A1 (en) 2016-09-13 2019-05-02 Allergan, Inc. Stabilized non-protein Clostridial toxin compositions
WO2018073370A1 (en) * 2016-10-21 2018-04-26 Toxogen Gmbh A functional detection assay devoid of antibodies for serotyping of botulinum neurotoxins
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804604A (en) 1989-12-21 1998-09-08 Biogen, Inc. Tat-derived transport polypeptides and fusion proteins
US5962637A (en) * 1994-06-03 1999-10-05 Microbiological Research Authority Toxin assay
GB9411138D0 (en) 1994-06-03 1994-07-27 Microbiological Res Authority Toxin assay
US20010046668A1 (en) * 1994-10-21 2001-11-29 G.D. Searle & Co. Fluorescence polarization method for determining protease activity
US5693476A (en) 1995-02-24 1997-12-02 The Board Of Trustees Of The Leland Stanford Junior University Methods of screening for compounds capable of modulating vesicular release
GB9508204D0 (en) 1995-04-21 1995-06-07 Speywood Lab Ltd A novel agent able to modify peripheral afferent function
US5804395A (en) * 1995-12-01 1998-09-08 The United States Of America As Represented By The Secretary Of The Navy Fluorescence polarization assays of enzymes and substrates therefore
US6803188B1 (en) 1996-01-31 2004-10-12 The Regents Of The University Of California Tandem fluorescent protein constructs
WO1997034620A1 (en) 1996-03-18 1997-09-25 The Regents Of The University Of California Peptide inhibitors of neurotransmitter secretion by neuronal cells
FI102922B (fi) * 1996-06-28 1999-03-15 Valtion Teknillinen Fluoresenssiin perustuva immunomääritysmenetelmä
WO1998005962A1 (en) * 1996-08-02 1998-02-12 Panvera Corporation A method for quantitating competitive binding of molecules to proteins utilizing fluorescence polarization
US5965699A (en) 1996-11-06 1999-10-12 The United States Of America As Represented By The Secretary Of The Army Assay for the proteolytic activity of serotype a from clostridium botulinum
US6197928B1 (en) 1997-03-14 2001-03-06 The Regents Of The University Of California Fluorescent protein sensors for detection of analytes
US6180340B1 (en) 1997-10-31 2001-01-30 Gen-Probe Incorporated Extended dynamic range assays
US6221355B1 (en) 1997-12-10 2001-04-24 Washington University Anti-pathogen system and methods of use thereof
DE69938293T2 (de) * 1998-03-27 2009-03-12 Bruce J. Beverly Hills Bryan Luciferase, gfp fluoreszenzproteine, kodierende nukleinsaüre und ihre verwendung in der diagnose
US6251583B1 (en) * 1998-04-27 2001-06-26 Schering Corporation Peptide substrates for HCV NS3 protease assays
CA2330560A1 (en) 1998-04-28 1999-11-04 Washington University Methods for transducing fusion molecules
DE69941085D1 (de) 1998-07-17 2009-08-20 Univ Maryland Manipulierte proteine zum analyten nachweis
WO2000034308A2 (en) 1998-12-10 2000-06-15 Washington University Protein transduction system and methods of use thereof
US6469154B1 (en) 1999-05-21 2002-10-22 The Regents Of The University Of California Fluorescent protein indicators
US6323039B1 (en) * 1999-06-22 2001-11-27 Mitokor Compositions and methods for assaying subcellular conditions and processes using energy transfer
US7105310B1 (en) * 2000-07-19 2006-09-12 California Institute Of Technology Detection of biomolecules by sensitizer-linked substrates
CA2379532A1 (en) 1999-08-20 2001-03-15 Imperial College Innovations Limited Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis
US6903187B1 (en) 2000-07-21 2005-06-07 Allergan, Inc. Leucine-based motif and clostridial neurotoxins
US20030219462A1 (en) 2000-07-21 2003-11-27 Allergan Sales, Inc Clostridial neurotoxin compositions and modified clostridial neurotoxins
AU2001279135A1 (en) * 2000-07-31 2002-02-13 Maxygen, Inc. Biosensors, reagents and diagnostic applications of directed evolution
CA2451909C (en) 2000-09-25 2010-12-21 James J. Schmidt High throughput assays for the proteolytic activities of clostridial neurotoxins
ATE412062T1 (de) * 2001-01-26 2008-11-15 Evotec Ag Verfahren und mittel zur detektion enzymatischer spalt- und verknüpfungsreaktionen
US7332567B2 (en) * 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
US7374896B2 (en) * 2001-08-28 2008-05-20 Allergan, Inc. GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
US20060063221A1 (en) * 2004-09-21 2006-03-23 Williams Dudley J Lanthanide-based substrates and methods for determining clostridial toxin activity
US7208285B2 (en) * 2001-08-28 2007-04-24 Allergan, Inc. Fret protease assays for botulinum serotype A/E toxins
US6504006B1 (en) 2001-10-12 2003-01-07 Nancy Rose Shine Substrate peptides and assays for detecting and measuring proteolytic activity of serotype A neurotoxin from clostridium botulinum
US7361478B2 (en) * 2001-11-20 2008-04-22 Allergan, Inc. High-throughput screen for identifying selective persistent sodium channels channel blockers
DE60321768D1 (de) * 2002-01-29 2008-08-07 Discoverx Inc Enzymaktivierungsprotease-assay
CA2485560A1 (en) * 2002-05-10 2004-06-03 Engeneos, Inc. Unique recognition sequences and methods of use thereof in protein analysis
US7183066B2 (en) * 2002-09-27 2007-02-27 Allergan, Inc. Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
AU2003272800A1 (en) 2002-10-01 2004-04-23 University Of Maryland Methods for identifying inhibitors of botulinum neurotoxins
US20040115727A1 (en) * 2002-12-11 2004-06-17 Allergan, Inc., A Corporation Evolved clostridial toxins with altered protease specificity
US7452690B2 (en) * 2003-01-28 2008-11-18 Discoverx Corporation Protease EFC cell surface fusion protein assay
WO2005003376A2 (en) * 2003-03-28 2005-01-13 The United States Of America As Represented By The Secretary Of The Navy Naval Medical Research Center, Code 00L Anthrax antigen vaccine cultures by fluorescence polarization
US7432070B2 (en) * 2003-06-16 2008-10-07 Pierce Biotechnology, Inc. Homogenous assay for enzymatic activity
US7198928B2 (en) * 2003-09-15 2007-04-03 Allergan, Inc. Human COX-1 alternatively spliced variants and methods of using same
US7408640B2 (en) * 2003-11-05 2008-08-05 The United States Of America As Represented By The Secretary Of The Navy Fluorescence polarization instruments and methods for detection of exposure to biological materials by fluorescence polarization immunoassay of saliva, oral or bodily fluids
US7531317B2 (en) * 2003-11-25 2009-05-12 Wisconsin Alumni Research Foundation Fluorescence polarization assay to detect protease cleavage
CA2550401C (en) * 2003-12-19 2015-12-08 Wisconsin Alumni Research Foundation Method and compositions for detecting botulinum neurotoxin
US20060024794A1 (en) * 2004-07-30 2006-02-02 Shengwen Li Novel methods for production of di-chain botulinum toxin
US7399607B2 (en) * 2004-09-22 2008-07-15 Allergan, Inc. Fluorescence polarization assays for determining clostridial toxin activity
EP1848812A4 (en) * 2004-10-01 2011-11-09 Life Technologies Corp SUPPLY BUFFERS, SYSTEMS AND METHODS FOR THE IN VITRO SYNTHESIS OF BIOMOLECULES
CA2602972C (en) * 2005-10-12 2013-09-24 Allergan, Inc. Assays of molecular or subcellular interactivity using depolarization after resonance energy transfer (daret)

Also Published As

Publication number Publication date
US20100081156A1 (en) 2010-04-01
US7399607B2 (en) 2008-07-15
US7632655B2 (en) 2009-12-15
US20080305509A1 (en) 2008-12-11
ES2928863T3 (es) 2022-11-23
US20080293085A1 (en) 2008-11-27
CA2581231A1 (en) 2007-01-04
EP2107112A1 (en) 2009-10-07
DE602005021981D1 (de) 2010-08-05
US7635574B2 (en) 2009-12-22
ATE472101T1 (de) 2010-07-15
US20080293084A1 (en) 2008-11-27
ES2345780T3 (es) 2010-10-01
AU2005333632A1 (en) 2007-01-04
US20100081155A1 (en) 2010-04-01
US7638294B2 (en) 2009-12-29
WO2007001358A3 (en) 2007-06-28
KR20070055609A (ko) 2007-05-30
JP2012210215A (ja) 2012-11-01
WO2007001358A2 (en) 2007-01-04
EP1807698A2 (en) 2007-07-18
JP2008513038A (ja) 2008-05-01
KR101442246B1 (ko) 2014-10-01
AU2005333632B2 (en) 2011-12-22
US7674601B2 (en) 2010-03-09
EP1807698B1 (en) 2010-06-23
US20060063222A1 (en) 2006-03-23
US20080305510A1 (en) 2008-12-11

Similar Documents

Publication Publication Date Title
DK1807698T3 (da) Assay til bestemmelse af aktiviteten af clostridialt toksin ved kombination af FRET og fluorescenspolarisering
CA2462686A1 (en) Fret protease assays for clostridial toxins
WO2004029576A3 (en) Cell-based fluorescence resonance energy transfer (fret) assays for clostridial toxins
DE602006014812D1 (de) Lostridientoxinaktivität
ATE532830T1 (de) Langwellige thiolgruppenreaktive fluorophore
WO2005045392A3 (en) Detection and identification of biopolymers using fluorescence quenching
DK2016421T3 (da) Reagenser og fremgangsmåder til detektering af proteiner ved hjælp af farvestoffer og dextriner
DE602004021185D1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
ATE456798T1 (de) Tests der molekularen oder subzellulären interaktivität unter verwendung von depolarisierung nach resonanzenergietransfer (daret)
DK1721162T3 (da) Fremgangsmåde til at bedömme rheumatoid arthritis ved at måle anti-CCP og serumamyloid A
DK1173770T3 (da) Fremgangsmåde til vurdering af risikoen for mavesår
Gilmore et al. Depolarization after resonance energy transfer (DARET): a sensitive fluorescence-based assay for botulinum neurotoxin protease activity
CA2318477A1 (en) Assay for specific strains of multiple disease related conformations of a protein
NO20053990L (no) Assay for proteinisoformer
DE60010323D1 (de) Fluoreszenzkorrelationsspektroskopie zur identifizierung von verbindung-ziel-bindung
ATE335816T1 (de) Verfahren zum nachweis prokaryontischer dna
CN112461802A (zh) 一种基于荧光共振能量转移的冠状病毒蛋白酶测活法
ATE389182T1 (de) Prion-assays mit hoher durchlaufleistung
DK1567661T3 (da) Fremgangsmåder, biosensorer og sæt til detektion og identificering af svampe
DE60323834D1 (de) Von bacillus cereus produzierte cereulid-synthase, diese codierendes gen und verfahren zum nachweis von cereulid
WO2007051256A1 (en) Method for monitoring protein digestion
Perpetuo et al. Enzymatic profiling of tetanus and botulinum neurotoxins based on vesicle-associated-membrane protein derived fluorogenic substrates
DE602006013869D1 (de) Verfahren zum spezifischen nachweis von legionella pneumophila
DE60118350D1 (de) Fluoreszenz-verfahren zum nachweis von proteasen oder peptidasen
BR0116199A (pt) Método para concentração de gene